Leica Biosystems, Indica Labs partner with Lunit
May 29, 2026—Leica Biosystems, Indica Labs, and Lunit are partnering to develop AI-powered image analysis algorithms.
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenter Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, July 15, 2026, 1:00-2:00 PM ET
Hear an expert discuss how to integrate Kappa and Lambda in situ hybridization testing into your standard hematopathology workflow to accurately assess B-cell and plasma cell clonality. You will also gain the skills to recognize testing pitfalls in challenging reactive versus neoplastic proliferations and apply ancillary tools to resolve complex cases.
Webinar presenter Xiaojun Wu, MD, PhD, Assistant professor, Director of Hematopathology Section at NCR of Johns Hopkins Medicine Department of Pathology, SOM at Johns Hopkins University
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, July 21, 2026, 11:00-11:30 AM CT
Roundtable presenters Nick Fingland, PhD, PMP, Senior Director, R&D Operations and Science, BD, and Chris Farnsworth, PhD, D(ABCC), Section Head of Clinical Chemistry, Professor of Pathology and Immunology, Washington University School of Medicine.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
May 29, 2026—Leica Biosystems, Indica Labs, and Lunit are partnering to develop AI-powered image analysis algorithms.
May 28, 2026—Seegene launched its new antimicrobial resistance testing product, the Allplex MDRO assay.
May 27, 2026—Horiba has launched Yumivet, its new veterinary diagnostics brand, and introduced the Yumivet VH2500 hematology analyzer.
May 26, 2026—FujiFilm Healthcare Americas has announced a strategic partnership with mTuitive under which it will integrate mTuitive’s structured pathology reporting platform with FujiFilm’s Synapse Pathology picture archiving and communication system.
May 21, 2026—Finland’s Grundium, backed by U.S.-based health care private equity firm EW Healthcare Partners, has acquired Visiopharm, of Denmark.
May 20, 2026—Anchor Molecular launched its BCR-ABL1 control panels designed to support laboratories in monitoring the performance of the quantitative detection of BCR-ABL1 translocation mRNA transcripts.
May 19, 2026—Streck has received in vitro diagnostic clearance for three MDx-Chex controls for sepsis testing.
May 18, 2026—The FDA has approved Natera’s Signatera CDx as a companion diagnostic for use with adjuvant atezolizumab (Tecentriq) immunotherapy in muscle-invasive bladder cancer to identify patients who are ctDNA molecular residual disease–positive and may benefit from treatment.
May 13, 2026—The following customer bulletin about A1CNow+ Controls (REF 737) is published at the request of Nova-One Diagnostics.
May 12, 2026—Streck launched CD-Chex Daily, a ready-to-use quality control for flow cytometry laboratories.